The Effect of IV Cangrelor and Oral Ticagrelor Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02733341
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- The Royal Wolverhampton Hospitals NHS Trust
- Registry
-
NCT02733341
-
- Other papers using this trial's data
- Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02733341. Randomized; no masking; primary purpose treatment. Start 2016-07-21 (actual); primary completion 2018-10-01 (actual). Results posted on 2025-05-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of IV Cangrelor and Oral Ticagrelor Study
- Condition
- Acute Coronary Syndrome (ACS)
- Condition
- High On-treatment Platelet Reactivity (HTPR)
- Condition
- Microvascular Obstruction (MVO)
- Condition
- ST-segment Elevation Myocardial Infarction (STEMI)
- Condition
- Thrombolysis in Myocardial Infarction (TIMI)
- Condition
- Unstable Angina (UA)
- Intervention (Drug)
- Cangrelor
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- The Royal Wolverhampton Hospitals NHS Trust
Record details
- Record id
cardio:ct-nct02733341- Content hash
c40b4091e696958d2c8d0ac4d865dc0b7efd07778c367085c8ab9719c58155ff